Together with the data presented here, as well as previous data showing LPAR1 involvement in IPF, we believe that there is a strong impetus for the development of PIPE-791 as a treatment for lung fibrosis. The gene discussed is LPAR1; the disease is idiopathic pulmonary fibrosis.